Chiang Chih-kang
Chiang Chih-kang is a prominent figure in the field of toxicology, currently serving as the director-general of Taiwan's Food and Drug Administration (FDA). Prior to this role, he was a professor at the National Taiwan University College of Medicine and the Graduate Institute of Toxicology. With a background in nephrology and a master’s degree in law, Chiang is well-equipped to address the complexities of public health, food safety, and regulatory issues. His appointment comes after a vacant period for the position, and he aims to enhance food safety, drug regulation, and medical device oversight through innovative technologies including artificial intelligence.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Taiwan:
Chiang Chih-kang is the FDA Director-General who reported on the camellia oil carcinogen issue.
5
Taiwan:
Food and Drug Administration Director-General Chiang Chih-kang stated that preliminary investigations indicated a link between heat loss and higher benzopyrene levels in oil.
7
Taiwan:
FDA Director-General Chiang Chih-kang speaks at a press conference in Taipei.
7
Taiwan:
FDA Director-General Chiang Chih-kang said that vendors who fail to remove the recalled items by the deadline would face severe penalties.
6
Taiwan:
FDA Director-General Chiang Chih-kang said that vendors who fail to remove the recalled items would face severe penalties.
6
Taiwan:
Food and Drug Administration Director-General Chiang Chih-kang answered questions from legislators at the Legislative Yuan in Taipei yesterday.
6
Taiwan:
FDA Director-General Chiang Chih-kang cited experts as saying that the incident might be linked to heat damage from post-harvest drying and fumigation of some Brazilian soybeans.
6
Taiwan:
Chiang Chih-kang, the FDA Director-General, spoke at a news conference regarding the Central Union oil contamination case.
7
Taiwan:
FDA Director-General Chiang Chih-kang said that this adjustment was made based on international and domestic scientific evidence.
8
Taiwan:
Food and Drug Administration Director-General Chiang Chih-kang said that Taiwan’s biomedical industry would face a transition with the implementation of the 'five strategies.'
7